CN100488526C - 仙硼疗氟口服制剂 - Google Patents
仙硼疗氟口服制剂 Download PDFInfo
- Publication number
- CN100488526C CN100488526C CNB2005100033237A CN200510003323A CN100488526C CN 100488526 C CN100488526 C CN 100488526C CN B2005100033237 A CNB2005100033237 A CN B2005100033237A CN 200510003323 A CN200510003323 A CN 200510003323A CN 100488526 C CN100488526 C CN 100488526C
- Authority
- CN
- China
- Prior art keywords
- add
- corydalis
- borax
- tablets
- oral
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 238000002360 preparation method Methods 0.000 title claims abstract description 21
- 241000218176 Corydalis Species 0.000 claims abstract description 21
- 229910021538 borax Inorganic materials 0.000 claims abstract description 20
- 239000004328 sodium tetraborate Substances 0.000 claims abstract description 20
- 235000010339 sodium tetraborate Nutrition 0.000 claims abstract description 20
- 229930187479 gypenoside Natural products 0.000 claims abstract description 13
- 239000003826 tablet Substances 0.000 claims abstract description 13
- ZRBFCAALKKNCJG-UHFFFAOYSA-N gypenoside-XVII Natural products C1CC(C2(CCC3C(C)(C)C(OC4C(C(O)C(O)C(CO)O4)O)CCC3(C)C2CC2O)C)(C)C2C1C(C)(CCC=C(C)C)OC(C(C(O)C1O)O)OC1COC1OC(CO)C(O)C(O)C1O ZRBFCAALKKNCJG-UHFFFAOYSA-N 0.000 claims abstract description 12
- 239000000284 extract Substances 0.000 claims abstract description 10
- 239000000463 material Substances 0.000 claims abstract description 9
- 239000008187 granular material Substances 0.000 claims abstract description 6
- 241000304195 Salvia miltiorrhiza Species 0.000 claims abstract description 4
- 235000011135 Salvia miltiorrhiza Nutrition 0.000 claims abstract description 4
- 239000002775 capsule Substances 0.000 claims abstract description 4
- 238000007796 conventional method Methods 0.000 claims abstract description 3
- 239000000243 solution Substances 0.000 claims abstract description 3
- 241000893536 Epimedium Species 0.000 claims abstract 4
- 235000008331 Pinus X rigitaeda Nutrition 0.000 claims abstract 4
- 235000011613 Pinus brutia Nutrition 0.000 claims abstract 4
- 241000018646 Pinus brutia Species 0.000 claims abstract 4
- 235000018905 epimedium Nutrition 0.000 claims abstract 4
- 229940126680 traditional chinese medicines Drugs 0.000 claims abstract 2
- YCKRFDGAMUMZLT-UHFFFAOYSA-N Fluorine atom Chemical compound [F] YCKRFDGAMUMZLT-UHFFFAOYSA-N 0.000 claims description 26
- 239000011737 fluorine Substances 0.000 claims description 26
- 229910052731 fluorine Inorganic materials 0.000 claims description 26
- 239000000706 filtrate Substances 0.000 claims description 12
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 12
- 235000021419 vinegar Nutrition 0.000 claims description 8
- 239000000052 vinegar Substances 0.000 claims description 8
- ZOXJGFHDIHLPTG-UHFFFAOYSA-N Boron Chemical compound [B] ZOXJGFHDIHLPTG-UHFFFAOYSA-N 0.000 claims description 6
- 229910052796 boron Inorganic materials 0.000 claims description 6
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 claims description 6
- 239000000203 mixture Substances 0.000 claims description 5
- 238000002560 therapeutic procedure Methods 0.000 claims description 5
- KRHYYFGTRYWZRS-UHFFFAOYSA-M Fluoride anion Chemical compound [F-] KRHYYFGTRYWZRS-UHFFFAOYSA-M 0.000 claims description 4
- 239000000843 powder Substances 0.000 claims description 4
- 235000019359 magnesium stearate Nutrition 0.000 claims description 3
- 239000006228 supernatant Substances 0.000 claims description 3
- 229920002472 Starch Polymers 0.000 claims description 2
- 239000012141 concentrate Substances 0.000 claims description 2
- 239000007935 oral tablet Substances 0.000 claims description 2
- 229940096978 oral tablet Drugs 0.000 claims description 2
- 239000011734 sodium Substances 0.000 claims description 2
- 229910052708 sodium Inorganic materials 0.000 claims description 2
- 239000008107 starch Substances 0.000 claims description 2
- 235000019698 starch Nutrition 0.000 claims description 2
- 241001072909 Salvia Species 0.000 claims 1
- 235000017276 Salvia Nutrition 0.000 claims 1
- 239000000546 pharmaceutical excipient Substances 0.000 claims 1
- 230000001225 therapeutic effect Effects 0.000 claims 1
- 239000003814 drug Substances 0.000 abstract description 48
- 208000004042 dental fluorosis Diseases 0.000 abstract description 18
- 206010016818 Fluorosis Diseases 0.000 abstract description 14
- 210000003734 kidney Anatomy 0.000 abstract description 14
- 230000000694 effects Effects 0.000 abstract description 13
- 208000002193 Pain Diseases 0.000 abstract description 10
- 230000036407 pain Effects 0.000 abstract description 10
- 210000000988 bone and bone Anatomy 0.000 abstract description 9
- 238000012360 testing method Methods 0.000 abstract description 7
- 231100000331 toxic Toxicity 0.000 abstract description 4
- 230000002588 toxic effect Effects 0.000 abstract description 4
- 210000002435 tendon Anatomy 0.000 abstract description 3
- 239000007938 effervescent tablet Substances 0.000 abstract description 2
- 230000007774 longterm Effects 0.000 abstract description 2
- 239000007901 soft capsule Substances 0.000 abstract description 2
- 230000008030 elimination Effects 0.000 abstract 1
- 238000003379 elimination reaction Methods 0.000 abstract 1
- 239000008280 blood Substances 0.000 description 13
- 210000004369 blood Anatomy 0.000 description 12
- 229940079593 drug Drugs 0.000 description 12
- 201000010099 disease Diseases 0.000 description 11
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 11
- 241000612166 Lysimachia Species 0.000 description 9
- 210000004185 liver Anatomy 0.000 description 9
- 230000017531 blood circulation Effects 0.000 description 8
- 230000001737 promoting effect Effects 0.000 description 8
- 208000006820 Arthralgia Diseases 0.000 description 6
- 210000003205 muscle Anatomy 0.000 description 6
- 208000020084 Bone disease Diseases 0.000 description 5
- 235000003140 Panax quinquefolius Nutrition 0.000 description 5
- 230000006378 damage Effects 0.000 description 5
- 239000000796 flavoring agent Substances 0.000 description 5
- 235000019634 flavors Nutrition 0.000 description 5
- 238000000034 method Methods 0.000 description 5
- 241000208340 Araliaceae Species 0.000 description 4
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 description 4
- 239000002671 adjuvant Substances 0.000 description 4
- 235000008434 ginseng Nutrition 0.000 description 4
- 210000004072 lung Anatomy 0.000 description 4
- 231100000957 no side effect Toxicity 0.000 description 4
- 210000000952 spleen Anatomy 0.000 description 4
- 208000001132 Osteoporosis Diseases 0.000 description 3
- 230000004087 circulation Effects 0.000 description 3
- 239000003651 drinking water Substances 0.000 description 3
- 235000020188 drinking water Nutrition 0.000 description 3
- 238000009472 formulation Methods 0.000 description 3
- 239000007788 liquid Substances 0.000 description 3
- 238000002156 mixing Methods 0.000 description 3
- 231100000862 numbness Toxicity 0.000 description 3
- 231100000614 poison Toxicity 0.000 description 3
- 230000002265 prevention Effects 0.000 description 3
- 239000000047 product Substances 0.000 description 3
- 238000011160 research Methods 0.000 description 3
- 210000002784 stomach Anatomy 0.000 description 3
- 238000005728 strengthening Methods 0.000 description 3
- IBGBGRVKPALMCQ-UHFFFAOYSA-N 3,4-dihydroxybenzaldehyde Chemical compound OC1=CC=C(C=O)C=C1O IBGBGRVKPALMCQ-UHFFFAOYSA-N 0.000 description 2
- RZVAJINKPMORJF-UHFFFAOYSA-N Acetaminophen Chemical compound CC(=O)NC1=CC=C(O)C=C1 RZVAJINKPMORJF-UHFFFAOYSA-N 0.000 description 2
- 208000025747 Rheumatic disease Diseases 0.000 description 2
- 230000000202 analgesic effect Effects 0.000 description 2
- 230000001684 chronic effect Effects 0.000 description 2
- 235000009508 confectionery Nutrition 0.000 description 2
- 230000007812 deficiency Effects 0.000 description 2
- 230000003203 everyday effect Effects 0.000 description 2
- 210000003414 extremity Anatomy 0.000 description 2
- 235000013305 food Nutrition 0.000 description 2
- 208000014674 injury Diseases 0.000 description 2
- 238000011835 investigation Methods 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 239000012567 medical material Substances 0.000 description 2
- BQJCRHHNABKAKU-KBQPJGBKSA-N morphine Chemical compound O([C@H]1[C@H](C=C[C@H]23)O)C4=C5[C@@]12CCN(C)[C@@H]3CC5=CC=C4O BQJCRHHNABKAKU-KBQPJGBKSA-N 0.000 description 2
- 230000001717 pathogenic effect Effects 0.000 description 2
- 231100000915 pathological change Toxicity 0.000 description 2
- 230000036285 pathological change Effects 0.000 description 2
- 239000002574 poison Substances 0.000 description 2
- GPTFURBXHJWNHR-UHFFFAOYSA-N protopine Chemical compound C1=C2C(=O)CC3=CC=C4OCOC4=C3CN(C)CCC2=CC2=C1OCO2 GPTFURBXHJWNHR-UHFFFAOYSA-N 0.000 description 2
- 150000003254 radicals Chemical class 0.000 description 2
- 230000000552 rheumatic effect Effects 0.000 description 2
- 230000008961 swelling Effects 0.000 description 2
- 210000001519 tissue Anatomy 0.000 description 2
- 239000003053 toxin Substances 0.000 description 2
- 231100000765 toxin Toxicity 0.000 description 2
- 210000002700 urine Anatomy 0.000 description 2
- 238000001291 vacuum drying Methods 0.000 description 2
- 210000001835 viscera Anatomy 0.000 description 2
- PAFLSMZLRSPALU-MRVPVSSYSA-N (2R)-3-(3,4-dihydroxyphenyl)lactic acid Chemical compound OC(=O)[C@H](O)CC1=CC=C(O)C(O)=C1 PAFLSMZLRSPALU-MRVPVSSYSA-N 0.000 description 1
- FBFMBWCLBGQEBU-RXMALORBSA-N (2s,3r,4s,5s,6r)-2-[(2r,3r,4s,5s,6r)-2-[[(3s,5r,6s,8r,9r,10r,12r,13r,14r,17s)-3,12-dihydroxy-4,4,8,10,14-pentamethyl-17-[(2s)-6-methyl-2-[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyhept-5-en-2-yl]-2,3,5,6,7,9,11,12,13,15,16,17-dodecah Chemical class O([C@@](C)(CCC=C(C)C)[C@@H]1[C@@H]2[C@@]([C@@]3(C[C@@H]([C@H]4C(C)(C)[C@@H](O)CC[C@]4(C)[C@H]3C[C@H]2O)O[C@H]2[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O2)O[C@H]2[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O2)O)C)(C)CC1)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O FBFMBWCLBGQEBU-RXMALORBSA-N 0.000 description 1
- 241000331777 Arisaema balansae Species 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 206010008685 Chondritis Diseases 0.000 description 1
- 206010051625 Conjunctival hyperaemia Diseases 0.000 description 1
- 206010010726 Conjunctival oedema Diseases 0.000 description 1
- 241000721047 Danaus plexippus Species 0.000 description 1
- PAFLSMZLRSPALU-QMMMGPOBSA-N Danshensu Natural products OC(=O)[C@@H](O)CC1=CC=C(O)C(O)=C1 PAFLSMZLRSPALU-QMMMGPOBSA-N 0.000 description 1
- 206010012735 Diarrhoea Diseases 0.000 description 1
- 239000009636 Huang Qi Substances 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 206010023232 Joint swelling Diseases 0.000 description 1
- 208000019255 Menstrual disease Diseases 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 241000475481 Nebula Species 0.000 description 1
- 240000005373 Panax quinquefolius Species 0.000 description 1
- 241000218180 Papaveraceae Species 0.000 description 1
- GTRPODKMSBFDOI-UHFFFAOYSA-N Protopine Natural products CN1Cc2c3OCOc3ccc2C4C1Cc5cc6OCOc6cc5C4=O GTRPODKMSBFDOI-UHFFFAOYSA-N 0.000 description 1
- ZAALQOFZFANFTF-UHFFFAOYSA-N Pseudoprotipine Natural products C1=C2C(=O)CC3=CC=4OCOC=4C=C3CN(C)CCC2=CC2=C1OCO2 ZAALQOFZFANFTF-UHFFFAOYSA-N 0.000 description 1
- PAFLSMZLRSPALU-UHFFFAOYSA-N Salvianic acid A Natural products OC(=O)C(O)CC1=CC=C(O)C(O)=C1 PAFLSMZLRSPALU-UHFFFAOYSA-N 0.000 description 1
- 229930183118 Tanshinone Natural products 0.000 description 1
- 206010044032 Tooth discolouration Diseases 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 240000008042 Zea mays Species 0.000 description 1
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 1
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 239000003513 alkali Substances 0.000 description 1
- 229930013930 alkaloid Natural products 0.000 description 1
- 150000003797 alkaloid derivatives Chemical class 0.000 description 1
- WYTGDNHDOZPMIW-RCBQFDQVSA-N alstonine Natural products C1=CC2=C3C=CC=CC3=NC2=C2N1C[C@H]1[C@H](C)OC=C(C(=O)OC)[C@H]1C2 WYTGDNHDOZPMIW-RCBQFDQVSA-N 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 208000002399 aphthous stomatitis Diseases 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 230000001914 calming effect Effects 0.000 description 1
- 125000002057 carboxymethyl group Chemical group [H]OC(=O)C([H])([H])[*] 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 239000003245 coal Substances 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 238000010668 complexation reaction Methods 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 238000010411 cooking Methods 0.000 description 1
- 235000005822 corn Nutrition 0.000 description 1
- 230000001186 cumulative effect Effects 0.000 description 1
- 230000002354 daily effect Effects 0.000 description 1
- 208000002925 dental caries Diseases 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- CHWPMFMUQATVNK-ARYYTZDLSA-N dihydrosporogen AO-1 Natural products O[C@H]1[C@]2(C(C)=C)O[C@@H]2[C@]2(C)[C@@H](C)[C@H](O)CCC2=C1 CHWPMFMUQATVNK-ARYYTZDLSA-N 0.000 description 1
- 230000006806 disease prevention Effects 0.000 description 1
- 239000002552 dosage form Substances 0.000 description 1
- 230000035622 drinking Effects 0.000 description 1
- 235000006694 eating habits Nutrition 0.000 description 1
- 206010015037 epilepsy Diseases 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 150000002222 fluorine compounds Chemical class 0.000 description 1
- 210000000610 foot bone Anatomy 0.000 description 1
- 235000012055 fruits and vegetables Nutrition 0.000 description 1
- 239000000446 fuel Substances 0.000 description 1
- 230000006870 function Effects 0.000 description 1
- 229940089161 ginsenoside Drugs 0.000 description 1
- 229930182494 ginsenoside Natural products 0.000 description 1
- 230000035876 healing Effects 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 230000009545 invasion Effects 0.000 description 1
- 239000003621 irrigation water Substances 0.000 description 1
- 230000003907 kidney function Effects 0.000 description 1
- 210000000629 knee joint Anatomy 0.000 description 1
- 210000002414 leg Anatomy 0.000 description 1
- 230000003859 lipid peroxidation Effects 0.000 description 1
- 230000003908 liver function Effects 0.000 description 1
- 239000002075 main ingredient Substances 0.000 description 1
- 206010025482 malaise Diseases 0.000 description 1
- 230000002175 menstrual effect Effects 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 229960005181 morphine Drugs 0.000 description 1
- 230000003119 painkilling effect Effects 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 239000008188 pellet Substances 0.000 description 1
- 229940023488 pill Drugs 0.000 description 1
- 239000006187 pill Substances 0.000 description 1
- 230000008092 positive effect Effects 0.000 description 1
- 230000003449 preventive effect Effects 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 230000002035 prolonged effect Effects 0.000 description 1
- 229960003371 protocatechualdehyde Drugs 0.000 description 1
- 230000001047 pyretic effect Effects 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 230000003014 reinforcing effect Effects 0.000 description 1
- 230000002040 relaxant effect Effects 0.000 description 1
- 210000002345 respiratory system Anatomy 0.000 description 1
- 108010048734 sclerotin Proteins 0.000 description 1
- 239000002689 soil Substances 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 208000037816 tissue injury Diseases 0.000 description 1
- 239000003440 toxic substance Substances 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 231100000820 toxicity test Toxicity 0.000 description 1
- 230000002936 tranquilizing effect Effects 0.000 description 1
- 230000008736 traumatic injury Effects 0.000 description 1
- 238000013022 venting Methods 0.000 description 1
- 230000035899 viability Effects 0.000 description 1
- 239000011800 void material Substances 0.000 description 1
- 238000010792 warming Methods 0.000 description 1
- 239000002912 waste gas Substances 0.000 description 1
- 238000005303 weighing Methods 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
- Medicinal Preparation (AREA)
Abstract
本发明专利申请是一种治疗氟骨病的中药制剂,它主要是采用由质量比为淫羊藿1500g~2500∶丹参1500~2500∶绞股蓝皂甙18~22∶延胡索1200g~1800g∶追风伞800g~1200∶松节700g~1100∶硼砂15~25的七味中药材,这些中药用常规方法炮制,再经过煎煮、提取浓缩得到浸膏,加入辅料,制成口服溶液、片剂、颗粒剂、泡腾片、胶囊、软胶囊各种口服制剂。它能益气补肾,强筋壮骨,除湿活络,祛毒定痛,促进体内的氟毒排除。经过试验证明,本品种有,具有起效快、作用稳定、携带服用方便、长期服用无毒副作用的特点。
Description
技术领域
本发明专利涉及一种中药制剂,尤其涉及一种对地方性氟病、氟骨病有治疗作用的中药制剂仙硼疗氟口服制剂。
背景技术
氟的分布甚广,食物及饮水多含有氟。谷类、水果及蔬菜的氟含量随土壤及灌溉水中氟的多少而定,人体对氟的需要量有一定范围,每日需要量为0.5~1毫克,缺氟会使人患龋齿病,过量的氟,对人体组织却是一种毒素,会使人患斑釉齿甚至氟骨病。氟骨病会导致骨质疏松、疼痛、关节肿大变形,甚至失去生活能力。
以中医的观点来看,地方氟病是由于久居在高氟地区,长期摄入过量的氟在体内蓄积,导致机体损伤而发生氟中毒,以氟骨病为主要表现。氟毒入侵机体,耗损气血,气血亏损,无以滋养脏腑,填补肾精,导致肾脏虚惫,“肾主骨生髓”,肾脏虚惫则出现一系列骨骼的病变全身症候。
据有的专家介绍,氟斑牙和氟骨病是一种只可预防不可医治的疾病,该病预防主要从:1 改变饮水、饮食习惯,降低饮用水氟含量;2、减少氟的吸收两方面着手。如一些高氟地区家中使用没有烟囱的敞开式炉,一家人做饭、取暖及烘粮食全靠此灶,用含有氟的泥和煤混和作燃料,燃烧后释放出大量的氟化物不但可以通过呼吸道进入人体,还可以附着在烘烤的玉米等粮食的表面,又习惯随食随取,长此以往,氟化物在人体内就越积越多,也就导致了年轻时得氟斑牙,成人后得氟骨病了。预防它们并不难,只要将村民们使用的敞开式炉灶改造成有烟道式,将燃烧后含有氟化物的废气通过烟囱排出屋外,即可起到预防作用。另外是保证饮用水中含氟量处于国家标准允许范围内。
氟中毒是一种在我国分布较为广泛的地方病。国内,也是在最近20年左右,在关注环境污染和地方病调查中,经过深入研究后发现其危害严重,急需采取措施进行防治的地方病。我国在辽宁、山东、贵州等地区有几千万人受到氟斑牙、氟骨病不同程度的危害。预防能够解决氟骨病的病人在这些区域今后的产生,而已经受到氟骨病侵害的病人如何才能得到专门治疗恢复健康,是摆在医疗工作者的一个面前的一个重要问题。在我国传统的中医药中尚未有此验方,仅有治疗类似骨病的一些药剂。如专利申请号为01114811.X名称为《一种预防和治疗骨质疏松及促进骨折愈合的药物及其生产方法》的专利申请介绍采用天然中药材当归、熟地黄、巴戟天、杜仲、山茱萸、淮山、川芎、枸杞子、制仙茅、炒龟板、黄芪、鹿角、红参、淫羊藿为主要原料,共同制成丸剂、口服液、胶囊剂、片剂或冲剂等口服剂型,本发明具有补肝肾、强筋骨、健脾胃、益气血、活血化瘀的作用,用于骨质疏松、骨质愈合缓慢、软骨炎及肝肾亏损等症的预防和治疗,无明显的毒副作用,其生产方法简单。国外,有采用排氟剂治疗的方法,如用复合硼砂制剂、70年代,印度有用蛇纹石溶剂排氟、还有用钙制剂等排氟,有一定的效果。但要求时间长,有一定副作用。
发明内容
本专利申请的目的是发明人根据现有治疗氟中毒药物的实际情况进行了研究工作,为了克服常用西药疗效不高,长期服用有一定副作用的问题,同时由于传统中药方面没有针对性强的专门的中药制剂,拟发明一种与现有类似药品相比,具有起效快、作用稳定、长期服用无毒副作用的、治疗氟中毒的中药口服制剂。
本制剂旨在益气补肾,强筋壮骨,除湿活络,祛毒定痛。采用仙灵脾(淫羊藿)为君药,丹参、绞股蓝为臣药相辅助,延胡索、追风伞、松节佐之,另取硼砂入药,以促氟毒排除。下面介绍各药材的性状:
仙灵脾(淫羊藿),性辛、甘、温。归肝、肾经。具有补肝益肾作用,肝主筋,肾主骨,益肝肾则筋骨自坚。又因其为辛温之品,能通行经络,祛除风寒湿痹,可解除筋骨萎软、孪急,风湿痹痛,麻木拘孪。
丹参(Salvia miltiorrhiza)异名赤参、山参、红参、红根等,性味:苦、微温。能活血祛瘀、安神宁心、排脓(见《中药大辞典》478页)。归心、肝经,祛瘀止痛,活血通经,可缓解热痹疼痛。《别录》:“主腰脊强、脚痹,亦以温通气血,故能宣络蠲痹。”又日:“丹参,其功在于活血行血,内之达脏腑而化瘀滞。
绞股蓝,归心、肺、脾、肾经,始载于明“救荒本草”,有消炎解毒之功。上世纪以来,日本及我国学者对其进行了大量的研究,发现它含有85种绞股蓝皂甙,其中11种与人参功效成份人参皂甙的化学结构完全相同,故有类似人参的功效:补气、益肺、补脾,有利于久病虚赢,增强全身的体质。仙灵脾辅以丹参、绞股蓝,有利于提高慢性氟中毒后机体的气质,并在改善氟中毒导致的骨骼及全身病损方面发挥积极的作用。近年来的研究表明,氟中毒,机体内自由基增多,对细胞的脂质过氧化过程加强,是导致损伤的主要环节。丹参中的丹参素、丹参酮、原儿茶醛与绞股蓝的功效成份—绞股蓝皂甙等都是强抗氧化剂,可增强抗氧化酶系统的能力,可清除过多的自由基,防止其对组织的损伤,故有助于阻断氟中毒造成组织损伤的中间环节,防止氟中毒发展。配方中如果使用绞股蓝提取的绞股蓝皂甙代替绞股蓝入药,则绞股蓝皂甙不用煎煮,制作工艺中在浸膏干燥粉碎后,将绞股蓝皂甙和硼砂与浸膏粉混匀加入药中。
延胡索异名,玄胡索,延胡,元胡索等。药材为罂粟科植物延胡索的块根。主产浙江。性味:辛、苦。在延胡索的块根中已提出10余种生物碱。功能主治:活血、散、理气、止痛。治心腹腰膝诸痛,月经不调和跌打损伤。归肝、胃、脾经,有活血,利气,止痛的功效。《纲目》:“延胡索,能行血中气滞,故专治一身上下诸痛,用之中的,妙不可言”。现代药理表明,延胡索含延胡索甲素、乙素、丑素及原阿片碱等,总碱的止痛效价约为吗啡的40%。
松节和追风伞均为贵州苗族常用以治腰、腿关节疼痛的药物。据《贵州省中药材、民族药材资料标准》记载,松节归肝、肾经。祛风燥湿,舒筋活络,活血止痛。用于关节疼痛,筋骨孪急,脚痹萎软;追风伞亦有祛风活络,活血止痛之功,用于风湿痹痛,四肢拘孪,本制剂采用松节和追风伞两味药为佐,能与仙灵脾发挥显著的协同作用。
此外,本制剂采用硼砂,旨在使蓄积休内的氟排出体外。治疗氟中毒,除针对其症候、病变基础及发病环节外,尚需排除体内的氟,去除病因。国内、外常用硼砂治疗慢性氟中毒,其机理是用硼络合氟使其从骨中排出,并从体内排出。
硼砂是硼砂矿石提炼出来的结晶体为矿物中药材,中医药书籍中多有报道,谓其性甘、咸、凉,归肺、胃经。多作外用,有清热解毒之功,适用于肺胃火盛,口舌生疮,咽喉肿烂,以及目赤肿痛,目生翳膜等。经方中以硼砂入药内服者有硼砂丸(《圣济总录》)、硼砂丹、硼砂散、冰硼散多种。现代临床医学中有报道与其他中药配方,治疗癫痫等,每日剂量达1.5g~3g长期服用一年以上,无毒副作用。
本发明仙硼疗氟口服制剂,其特征在于采用淫羊藿1500~2500∶丹参1500~2500∶绞股蓝皂甙18~22∶延胡索1200~1800∶追风伞800~1200∶松节700~1100∶硼砂15~25(质量比)七味中药材,这些中药用常规方法炮制,再经过煎煮、提取浓缩得到相对密度为1.35~1.40(60℃)浸膏,加入常规辅料,制成口服溶液、片剂、颗粒剂、泡腾片、胶囊、软胶囊各种口服制剂。
本发明仙硼疗氟口服制剂,其特征在于最佳配方为淫羊藿2000∶丹参2000∶绞股蓝皂甙20∶延胡索1500∶追风伞1000∶松节900∶硼砂20(质量比),加入常规辅料,共制1000份(瓶、片、袋、盒、粒)的口服制剂。
本发明仙硼疗氟口服制剂,其特征在于它的口服片剂制取方法为七味中药材按上述配方的质量比分别取出,其中取延胡索,加醋(按延胡索∶醋=100∶20比例),置锅内共煮,至醋吸尽,取出与淫羊藿、丹参、追风伞、松节,加水10倍煎煮3小时过滤得滤液,再加水8倍煎煮2小时过滤得滤液,最后再加水6倍煎煮1小时过滤得滤液,合并滤过煎液,滤液浓缩到在60℃下相对密度为1.02~1.08浸膏,静置24小时,取上层清液浓缩到相对密度为1.35~1.40(60℃)浸膏,真空干燥,粉碎。取绞股蓝皂甙、硼砂与上述浸膏粉混匀,加入辅料硬脂酸镁或羧甲基淀粉钠,制粒,压制成1000份(片剂),包衣,即得本发明仙硼疗氟片。
需要说明的是,这几种中药材都为常用中药材,它们均无毒副作用。在许多地方的中医药验方中,它们分别都在口服药剂中使用。所以这里就不再列出本药剂的动物的毒性试验报告情况。本发明的仙硼疗氟片的服用方法为:一次4片,早晚各一次,三月为一疗程。其中一种的规格为每片质量0.35g~0.45g,根据配方、各种药剂标准中规定了主要成份的含量,同时按不同药剂标准中所规定的成分,确定加入辅料种类和重量。
本发明的药剂与现有的治疗氟骨病的药剂相比,具有起效快、作用稳定、携带服用方便、长期服用无毒副作用的特点。
具体实施方式
实施例1:分别称取淫羊藿1000g、丹参1000g、绞股蓝皂甙10g、延胡索750g、追风伞500g、松节450g,取延胡索加醋150g,置锅内共煮,至醋吸尽,取出与淫羊藿、丹参、追风伞、松节加水10倍煎煮3小时过滤得滤液,再加水8倍煎煮2小时过滤得滤液,最后再加水6倍煎煮1小时过滤得滤液,合并三次滤过煎液,滤液浓缩到在60℃下相对密度为1.02~1.08浸膏,静置24小时,取上层清液,浓缩到相对密度为1.35~1.40(60℃)浸膏,取真空干燥,粉碎。取绞股蓝皂甙10g、硼砂10g与上述浸膏粉混匀,加适当量辅料硬脂酸镁,制粒,压制成共制1000片,每片质量0.35g~0.45g。
临床试验情况,采用本药剂进行临床治疗观察的情况综合报告如下:
1 一般资料:
试验组100例中男36例,女64例;年龄30~74岁,平均(59.8±8.6)岁;病程5.0~14.0年,平均(9.6±5.6)年。对照组中男43例,女47例;年龄29~73岁,平均(59.7±8.5)岁;病程4.5~13.5年,平均(9.5±5.5)年。
2 受试对象选择、疗效判定均依照中华人民共和国国家食品药品监督管理局制定的中药新药临床研究指导原则。
3 用药方法、剂量及观察项目:
试验组:采用本口服制剂片剂,每日2次,每次4片用开水泡服。三个月为一个疗程。
对照组:服用硼砂,使用方法:1次25mg-50mg,1日3次。三个月为一个疗程。
观察项目:
(1)化验检查:血F-含量、尿F-含量、血SOD活性、MDA含量;。
(2)X光检查:四肢及脊柱、盆骨X光照片各取正侧照片各一张。
将服药前后的上述检查结果进行比较。
4 安全性观测:血、尿、便三大常规及心电图、肝功能、肾功能治疗前后各做一次。观察用药后的不良和毒性反应。
5 试验结果
试验组100例,有效者达90例,有效率为90.0%,对照组90例,有效者80例,有效率88.9%。说明试验组总有效率与对照组相当。
6 毒副作用
试验组用药后未见明显毒副反应;对照组有6例患者出现了恶心、呕吐及腹泻。
Claims (3)
1、仙硼疗氟口服制剂,其特征是采用按质量配比取出淫羊藿1500~2500:丹参1500~2500:绞股蓝皂甙18~22:延胡索1200~1800:追风伞800~1200:松节700~1100:硼砂15~25的七味中药材,这些中药用常规方法炮制,再经过煎煮、提取,在60℃下浓缩得到相对密度为1.35~1.40的浸膏,加入常规辅料,制成口服溶液、片剂、颗粒剂、胶囊的各种口服制剂。
2、根据权利要求1所述的仙硼疗氟口服制剂,其特征是按质量比的配方为淫羊藿1000:丹参1000:绞股蓝皂甙10:延胡索750:追风伞500:松节450:硼砂10,加入常规辅料,共制1000份瓶装、或片状、或袋装、或盒装、或粒状的口服制剂。
3、根据权利要求1所述的仙硼疗氟口服制剂,其特征是它的口服片剂制取方法为七味中药材按上述配方的质量比分别取出,其中取延胡索,按延胡索∶醋=100∶20比例加醋,置锅内共煮,至醋吸尽,取出与淫羊藿、丹参、追风伞、松节,加水10倍煎煮3小时过滤得滤液,再加水8倍煎煮2小时过滤得滤液,最后再加水6倍煎煮1小时过滤得滤液,合并滤过煎液,滤液浓缩到在60℃下相对密度为1.02~1.08浸膏,静置24小时,取上层清液在60℃下浓缩到相对密度为1.35~1.40浸膏,真空干燥,粉碎。取绞股蓝皂甙、硼砂与上述浸膏粉混匀,加入辅料硬脂酸镁或羧甲基淀粉钠,制粒,压制成1000份片剂,包衣,即得仙硼疗氟片。
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNB2005100033237A CN100488526C (zh) | 2005-12-15 | 2005-12-15 | 仙硼疗氟口服制剂 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNB2005100033237A CN100488526C (zh) | 2005-12-15 | 2005-12-15 | 仙硼疗氟口服制剂 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN1813876A CN1813876A (zh) | 2006-08-09 |
| CN100488526C true CN100488526C (zh) | 2009-05-20 |
Family
ID=36906308
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CNB2005100033237A Expired - Fee Related CN100488526C (zh) | 2005-12-15 | 2005-12-15 | 仙硼疗氟口服制剂 |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN100488526C (zh) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104740589A (zh) * | 2015-04-21 | 2015-07-01 | 杜卫卫 | 一种治疗氟骨症的中药制剂 |
| CN105147924B (zh) * | 2015-10-23 | 2016-06-29 | 王蕾 | 一种水香柴中西药复方壮骨镇痛口服液及其制备方法 |
-
2005
- 2005-12-15 CN CNB2005100033237A patent/CN100488526C/zh not_active Expired - Fee Related
Non-Patent Citations (2)
| Title |
|---|
| 中医药对氟骨症的治疗研究. 周振荣等.内蒙古预防医学,第21卷第2期. 1996 * |
| 氟骨症的临床表现与治疗. 郭世绂.临床医学杂志,第5卷第1期. 1989 * |
Also Published As
| Publication number | Publication date |
|---|---|
| CN1813876A (zh) | 2006-08-09 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN103041256B (zh) | 一种治疗小儿反复呼吸道感染的中药制剂 | |
| CN101757591A (zh) | 一种治疗慢性结肠炎、直肠炎的中药组合物 | |
| CN104027462A (zh) | 一种治疗骨关节炎的中药制剂及其制备方法 | |
| CN102430105A (zh) | 一种治疗慢性胃炎的中药组合物 | |
| CN103041255B (zh) | 治疗小儿咽喉肿痛呼吸道感染的中药制剂 | |
| CN104784508B (zh) | 用于提高恶性肿瘤患者免疫功能的中药制剂的制备方法 | |
| CN100488526C (zh) | 仙硼疗氟口服制剂 | |
| CN104042981A (zh) | 一种治疗产后便秘的药剂及制备方法 | |
| CN104958677A (zh) | 一种治疗膜性肾病的中药制剂及其制备方法 | |
| CN105521332A (zh) | 治疗肛裂的中药组合物及其制备方法和应用 | |
| CN104984237A (zh) | 一种中药组合物及其制备方法 | |
| CN104784509B (zh) | 用于提高恶性肿瘤患者免疫功能的中药制剂 | |
| CN102218131A (zh) | 一种生肌接骨外用中草药组合物 | |
| CN101695534B (zh) | 治疗乳腺疾病的中成药 | |
| CN101229297A (zh) | 一种用于治疗内外混合痔等疾病的中草药凉茶制剂 | |
| CN105477384A (zh) | 一种降低血压的中药组合物及其制备方法 | |
| CN105327024A (zh) | 一种治疗类风湿性关节炎的中药制剂 | |
| CN105055844A (zh) | 一种治疗慢性便秘的中药制剂 | |
| CN103845493A (zh) | 一种治疗急性腰扭伤的内服中药及其制备方法 | |
| CN103127398A (zh) | 一种治疗癌症的中药及其制备方法 | |
| CN103006957A (zh) | 一种预防和治疗骨质疏松的药物组合物及其制备方法 | |
| CN103655935A (zh) | 一种治疗乙肝的中药组合物 | |
| CN111658718A (zh) | 用于补肾的组合物、口服制剂及应用 | |
| CN107789427A (zh) | 一种用于治疗中老年突发性眩晕的中药胶囊 | |
| CN107789428A (zh) | 一种用于治疗中老年突发性眩晕的中药汤剂 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| CF01 | Termination of patent right due to non-payment of annual fee | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20090520 Termination date: 20161215 |